The Association of the British Pharmaceutical Industry (ABPI) said today that it would be studying the Office of Fair Trading’s market study into new and proposed medicine distribution arrangements in close detail.

 

​The choice of distribution arrangements by companies is a matter for their commercial judgement, providing that patient safety, supply chain security, speed of service to pharmacists and general efficiency are maintained.

The ABPI added that the pharmaceutical industry is already working with the UK Government on how medicines can be delivered to the NHS with the maximum efficiency. The OFT recommendations will be considered in parallel with these discussions.

 
 
Print this page icon Print this page
 
Please choose the subject of your enquiry from the list below:
 
Code to enter for submitting the form
Enter the above code here:
Can't read? Try different words.